Key Facts Some 3,000 participants with Type 2 diabetes and opioid use disorder were prescribed semaglutide and another 29,972 were prescribed other diabetic medications between December 2017 and December 2023, according to the study published Wednesday in JAMA Network Open
Disclaimer The content and materials presented or linked to are for informational and educational purposes only and do not constitute financial advice or recommendations and should not be considered as such.
Members get the real, FDA-approved product
6 Whether deliberately losing weight reduces the risk of recurrence is a more complicated question
Research Links Ozempic to Increased Risk of Blood Clots The medical community has been exploring how Ozempic may cause blood clots in people who take the drug for diabetes or weight loss
It naturally occurs in the body, is mostly produced in the liver and its primary purpose is to counteract toxins and reduce oxidative stress